LapidesJDioknoACSilberSMLoweBS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. Journal of Urology2002;167: 1584–6, 1972.
2.
StöhrerMBlokBCastro-DiazDChartier-KastlerEDel PopoloGKramerG. EAU guidelines on neurogenic lower urinary tract dysfunction. European Urology2009;56: 81–8.
3.
McCarthyC. Extracellular ATP signalling pathways in detrusor smooth muscle. PhD thesis. University College London; 2006.
4.
BusbyAAbramskyLDolkHArmstrongB. Preventing neural tube defects in Europe; population based study. British Medical Journal2005;330: 574–5.
5.
VerhoefMLurvinkMBarfHAPostMWvan AsbeckFWGooskensRH. High prevalence of incontinence among young adults with spina bifida: Description, prediction and problem perception. Spinal Cord2005;43: 331–40.
6.
PorruDCampusGGarauASorgiaMPauACSpiniciG. Urinary tract dysfunction in multiple sclerosis: Is there a relation with disease-related parameter?Spinal Cord1997;35: 33–6.
7.
FowlerCJPanickerJNDrakeMHarrisCHarrisonSCWKirbyM. AUK consensus on the management of the bladder in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry2009;80: 470–7.
8.
NorrisJPStaskinDR. History, physical examination, and classification of neurogenic voiding dysfunction. Urologic Clinics of North America1996;23: 337–43.
9.
MadersbacherH. The various types of neurogenic bladder dysfunction: An update of current therapeutic concepts. Paraplegia1990;28: 217–29.
10.
StöhrerMGoepelMKondoAKramerGMadersbacherHMillardR. Neurourol urodyn. The standardization of terminology in neurogenic lower urinary tract dysfunction: With suggestions for diagnostic procedures. International Continence Society Standardization Committee1999;18 (2): 139–58.
11.
CostaPPerrouin-VerbeBColvezADidierJMarquisPMarrelA. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of Qualiveen. European Urology2001;39: 107–13.
12.
PodnarSFowlerC. Electrophysiological evaluation: Basic principles and clinical applications. In: CorcosJSchirkE, editors. Textbook of neuropathic bladder. UK: Martin Dunitz, Taylor & Francis; 2004. p. 441–62.
13.
ChancellorMBAndersonRUBooneTB. Pharmacotherapy for neurogenic detrusor overactivity. American Journal of Physical Medicine and Rehabilitation2006;85: 536–45.
14.
BuyseGWaldeckKVerpoortenCBjörkHCasaerPAnderssonKE. Intravesical oxybutynin for neurogenic bladder dysfunction: Less systemic side effects due to reduced first pass metabolism. Journal of Urology1998;160 (September (3 Pt 1)): 892–6.
15.
ShohrerMPannekJ. Surgery to improve reservoir function. In: CorcosJSchickE, editors. Textbook of the neuropathic bladder. 2nd ed.London, UK: Informa Healthcare; 2008. p. 634–41.
16.
Perrouin-VerbeBLabatJJRichardIde la GreveI MauduytBuzelinJMMatheJF. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia1995;33 (November (11)): 619–24.
17.
TalbotHSMahonyEMJaffeeSR. The effect of prolonged urethral catheterization: I. Persistence of normal renal structure and function. Journal of Urology1959;81: 138–43.
18.
HamidRBycroftJAryaMShahPJ. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: Is it valid?Journal of Urology2003;170: 425–7.
19.
McClurgDAsheRGMarshallKLowe-StrongAS. Comparison of pelvic floor muscle training, electromyography, biofeedback and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: A randomised pilot study. Neurourology and Urodynamics2006;25: 337–48.
20.
SchurchBSchmidDMStöhrerM. Treatment of neurogenic incontinence with Botulinum toxin A. New England Journal of Medicine2000;342 (9): 665, 2.
21.
HaferkampASchurchBReitzAKrengelUGrosseJKramerG. Lack of ultrastructural detrusor changes following endoscopic injection of Botulinum toxin type A in overactive neurogenic bladder. European Urology2004;46: 784–91.
22.
Del PopoloGFilocamoMTLi MarziVMacchiarellaACecconiFLombardiG. Neurogenic detrusor overactivity treated with English Botulinum toxin a: 8-year experience of one single centre. European Urology2008;53: 1013–9.
23.
ApostolidisADasguptaPDenysPElneilSFowlerCJGiannantoniA. (Recommendations on the use of Botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European consensus report. European Urology2009;55: 100–19.
24.
KhastgirJHamidRAryaMShahNShahPJ. Surgical and patient reported outcomes of ‘clam’ augmentation ileocystoplasty in spinal cord injured patients. European Urology2003;43: 263–9.
25.
GreenwellTJVennSNMundyAR. Augmentation cystoplasty. British Journal of Urology International2001;88: 511–25.
26.
LengWWBlalockHJFredrikssonWHEnglishSFMcGuireEJ. Enterocystoplasty or detrusor myomectomy? Comparison of indications and outcomes for bladder augmentation. Journal of Urology1999;161: 758–63.
27.
BennettJKGreenBGFooteJEGrayM. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Paraplegia1995;33: 697–700.
28.
HamidRAryaMKhastgirJPatelHRShahPJ. The treatment of male stress urinary incontinence with polydimethylsiloxane in compliant bladders following spinal cord injury. Spinal Cord2003;41: 286–9.
29.
DecterRM. Use of the fascial sling for neurogenic incontinence: Lessons learned. Journal of Urology1993;150: 683–6.
30.
Abdul-RahmanAAttarKHHamidRShahPJ. Long-term outcome of tension-free vaginal tape for treating stress incontinence in women with neuropathic bladders. British Journal of Urology International2010;106: 827–30.
31.
KastlerECGenevoisSGaméXDenysPRichardFLericheA. Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: A French retrospective multicentre study. British Journal of Urology International2011;107 (3): 426–32.
32.
PatkiPHamidRShahPJCraggsM. Long-term efficacy of AMS 800 artificial urinary sphincter in male patients with urodynamic stress incontinence due to spinal cord lesion. Spinal Cord2006;44: 297–300.
33.
ChancellorMBErhardMJKiilholmaPJKarasickSRivasDA. Functional urethral closure with pubovaginal sling for destroyed female urethra after long-term urethral catheterization. Urology1994;43: 499–505.
34.
ZimmernPEHadleyHRLeachGERazS. Transvaginal closure of the bladder neck and placement of a suprapubic catheter for destroyed urethra after long-term indwelling catheterization. Journal of Urology1985;134: 554–7.
35.
BrindleyGS. An implant to empty the bladder or close the urethra. Journal of Neurology, Neurosurgery and Psychiatry1977;40: 358–69.
36.
SchurchBRodicBJeanmonodD. Posterior sacral rhizotomy and intradural anterior sacral root stimulation for treatment of the spastic bladder in spinal cord injured patients. Journal of Urology1997;157: 610–4.
37.
SchmidtRATanaghoEA. Feasibility of controlled micturition through electric stimulation. Urologia Internationalis1979;34: 199–230.
38.
BraunPMBaeznerHSeifCBoehlerGBrossSEschenfelderCC. Alterations of cortical electrical activity in patients with sacral neuromodulator. European Urology2002;41: 562–6.
39.
KesslerTMLa FramboiseDTrelleSFowlerCJKissGPannekJ. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: Systematic review and meta-analysis. European Urology2010;58 (6): 865–74.
40.
KaplanSAChancellorMBBlaivasJG. Bladder and sphincter behaviour in patients with spinal cord injury. Journal of Urology1991;146: 113.
41.
StöhrerMKramerGLöchner-ErnstDGoepelMNollFRübbenH. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients. European Urology Update Series1994;3: 170–5.
42.
Seoane-RodríguezSR-LosadaJ SánchezMontoto-MarquésAla BarreraS Salvador-deFerreiro-VelascoMEAlvarezCasteloL. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor—sphincter dyssynergia. Spinal Cord2007;45: 621–6.
43.
HamidRAryaMPatelHRShahPJ. The mesh wallstent in the treatment of detrusor external sphincter dyssynergia in men with spinal cord injury: A 12-year follow-up. British Journal of Urology International2003;91: 51–3.
44.
PhelanMWFranksMSomogyiGTYokoyamaTFraserMOLavelleJP. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. Journal of Urology2001;165: 1107–10.
45.
LiardASéquier-LipszycEMathiotAMitrofanoffP. The Mitrofanoff procedure: 20 years later. Journal of Urology2001;165: 2394–8.
46.
SyloraJAGonzalezRVaughnMReinbergY. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. Journal of Urology1997;157: 48–50.
47.
Castro-DiazDBarrettDGrisePPerkashIStohrerMStoneA. Surgery for the neuropathic patient. In: AbramsPKhourySWeinA, editors. Incontinence. 2nd edn.Plymouth: Health Publication; 2002. p. 865–91.
48.
HerschornSRangaswamySRadomskiSB. Urinary undiversion in adults with myelodysplasia: Longterm followup. Journal of Urology1994;152: 329–33.
49.
ShahNKabirMJLaneTAvenellSShahPJ. Vesicoureteric reflux in adults with neuropathic bladders treated with polydimethylsiloxane (Macroplastique). Spinal Cord2001;39: 92–6.
50.
GranataCBuffaPDi RovasendaEMattioliGScarsiPLPodestaE. Treatment of vesico-ureteric reflux in children with neuropathic bladder: A comparison of surgical and endoscopic correction. Journal of Pediatric Surgery1999;34: 1836–8.
51.
ShergillISAryaMHamidRKhastgirJPatelHRShahPJ. The importance of autonomic dysreflexia to the urologist. British Journal of Urology International2004;93: 923–6.
